Additionally, in samples derived from patients with lymph node metastasis, higher BMP2 expression levels correlated with higher expression levels of the mesenchymal marker vimentin (Fig. 1C,D and Supplementary Fig. 1). This evidence concerns the gene BMP2 and metastatic malignant neoplasm in the lymph nodes.